Back to Careers

‘Insulin for muscle’ and the AI platform behind it, with CEO Dr. Hanadie Yousef

Back to Careers

Pharmaphorum Spotlights Juvena’s AI Platform for Muscle and Metabolic Regeneration in Interview with CEO, Dr. Hanadie Yousef

Back to Careers

Who Are Today’s Biotech Underdogs and What Will It Take for Them to Succeed?

Back to Careers

Weight Loss for Longevity? How Metabolic Drugs are Disrupting Chronic Disease and Improving Healthspan

Back to Careers

Juvena Therapeutics and Lilly Enter Research Collaboration Focused on Muscle Health

Back to Careers

Lilly Bites Again in $650M Muscle-Preserving Treatment Pact With Juvena

Back to Careers

Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs

Back to Careers

Dr. Hanadie Yousef participates in the World Economic Forum’s Innovator Communities Meeting and Global Technology Retreat- and shares her expert insights on 2 panels: “Breaking Barriers: Funding Frontier Tech” and “Innovation to Impact: Commercialization Insights from the Field”

Back to Careers

CEO Dr. Hanadie Yousef discusses how the success of GLP-1/GIP receptor agonists is reshaping the treatment of chronic metabolic diseases and driving the next wave of therapeutics targeting the biology of aging at BIO 2025 in Boston

Back to Careers

CEO Dr. Hanadie Yousef joins a panel of industry leaders at BIO 2025 to explore how emerging therapeutic categories are reshaping dealmaking strategies, investment trends, and positioning in today’s evolving biotech landscape